DISCLAIMER: This document has been translated from a part of the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.
December 11, 2025
Company name: Pharma Foods International Co., Ltd. Listing: Tokyo Stock Exchange
Securities code: 2929
URL: https://www.pharmafoods.co.jp/ Representative: Mujo Kim, President
Inquiries: Seiyu Harada, General Manager of Corporate Strategy Department Telephone: +81-75-394-8600
Scheduled date to commence dividend payments: -
Preparation of supplementary material on financial results: Yes
Holding of financial results briefing: None
(Yen amounts are rounded down to millions, unless otherwise noted.)
-
Consolidated financial results for the three months ended October 31, 2025 (from August 1, 2025 to October 31, 2025)
-
Consolidated operating results (cumulative) (Percentages indicate year-on-year changes.)
Net sales
Operating profit
Ordinary profit
Profit attributable to owners of parent
Three months ended
Millions of yen
%
Millions of yen
%
Millions of yen
%
Millions of yen
%
October 31, 2025
15,712
7.6
(2,511)
-
(2,644)
-
(1,891)
-
October 31, 2024
14,596
(9.6)
882
46.7
888
46.7
360
25.9
Note: Comprehensive income For the three months ended October 31, 2025:
¥(1,807) million
[-%]
For the three months ended October 31, 2024:
¥314 million
[(21.8)%]
Basic earnings per share
Diluted earnings per share
Three months ended
Yen
Yen
October 31, 2025
(65.52)
-
October 31, 2024
12.86
-
- Consolidated financial position
Total assets
Net assets
Equity-to-asset ratio
As of
Millions of yen
Millions of yen
%
October 31, 2025
32,624
9,379
28.7
July 31, 2025
32,649
11,547
35.4
Reference: Equity
As of October 31, 2025: ¥9,379 million
As of July 31, 2025: ¥11,547 million
-
Consolidated operating results (cumulative) (Percentages indicate year-on-year changes.)
-
Cash dividends
Annual dividends per share
First quarter-end
Second quarter-end
Third quarter-end
Fiscal year-end
Total
Yen
Yen
Yen
Yen
Yen
Fiscal year ended July 31, 2025
-
12.50
-
12.50
25.00
Fiscal year ending July 31, 2026
-
Fiscal year ending July 31, 2026
(Forecast)
12.50
12.50
25.00
Note: Revisions to the forecast of cash dividends most recently announced: None
- Forecast of consolidated financial results for the fiscal year ending July 31, 2026 (from August 1, 2025 to July 31, 2026)
(Percentages indicate year-on-year changes.)
Net sales | Operating profit | Ordinary profit | Profit attributable to owners of parent | Basic earnings per share | |||||
Fiscal year ending July 31, 2026 | Millions of yen 68,000 | % 4.2 | Millions of yen 1,500 | % (36.6) | Millions of yen 1,500 | % (41.2) | Millions of yen 1,000 | % 171.7 | Yen 34.64 |
Note: Revisions to the earnings forecasts most recently announced: None
* NotesSignificant changes in the scope of consolidation during the period: None
Adoption of accounting treatment specific to the preparation of quarterly consolidated financial statements: None
Changes in accounting policies, changes in accounting estimates, and restatement
Changes in accounting policies due to revisions to accounting standards and other regulations: None
Changes in accounting policies due to other reasons: None
Changes in accounting estimates: None
Restatement: None
Number of issued shares (common shares)
Total number of issued shares at the end of the period (including treasury shares)
As of October 31, 2025
29,079,000 shares
As of July 31, 2025
29,079,000 shares
Number of treasury shares at the end of the period
As of October 31, 2025
211,706 shares
As of July 31, 2025
206,978 shares
Average number of shares outstanding during the period (cumulative from the beginning of the fiscal year)
Three months ended October 31, 2025 | 28,868,270 shares |
Three months ended October 31, 2024 | 28,070,082 shares |
Review of the Japanese-language originals of the attached consolidated quarterly financial statements by certified public accountants or an audit firm:Yes (optional)
Proper use of earnings forecasts, and other special matters
(Cautions on forward-looking statements, etc.)
The forward-looking statements, including forecasts of financial results, contained in these materials are based on information currently available to the Company and on certain assumptions deemed to be reasonable. However, the Company makes no guarantee that these forecasts will be achieved. Actual financial results, etc. may differ substantially due to various factors. For the assumptions and other matters related to the above forecasts, please refer to "1. Summary of Operating Results, etc. (3) Explanation of Forward-Looking Information such as Consolidated Earnings Forecasts."
Quarterly consolidated balance sheet(Millions of yen)
As of July 31, 2025 As of October 31, 2025Assets | ||
Current assets | ||
Cash and deposits | 9,157 | 8,673 |
Notes and accounts receivable - trade | 5,038 | 4,323 |
Electronically recorded monetary claims - operating | 247 | 285 |
Merchandise and finished goods | 6,311 | 6,890 |
Work in process | 675 | 660 |
Raw materials and supplies | 864 | 827 |
Other | 1,576 | 1,197 |
Allowance for doubtful accounts | (0) | (0) |
Total current assets | 23,870 | 22,858 |
Non-current assets | ||
Property, plant and equipment | ||
Buildings and structures, net | 2,082 | 2,044 |
Machinery, equipment and vehicles, net | 708 | 682 |
Tools, furniture and fixtures, net | 518 | 485 |
Land | 1,194 | 1,194 |
Leased assets, net | 27 | 26 |
Construction in progress | 164 | 352 |
Total property, plant and equipment | 4,696 | 4,785 |
Intangible assets | ||
Goodwill | 71 | 62 |
Other | 49 | 48 |
Total intangible assets | 120 | 111 |
Investments and other assets | ||
Investment securities | 2,450 | 2,643 |
Deferred tax assets | 515 | 1,235 |
Other | 996 | 989 |
Total investments and other assets | 3,961 | 4,868 |
Total non-current assets | 8,778 | 9,766 |
Total assets | 32,649 | 32,624 |
(Millions of yen)
As of July 31, 2025 | As of October 31, 2025 | |||
Liabilities | ||||
Current liabilities | ||||
Notes and accounts payable - trade | 1,923 | 1,588 | ||
Short-term borrowings | 11,400 | 13,900 | ||
Current portion of long-term borrowings | 560 | 500 | ||
Accounts payable - other | 3,520 | 5,460 | ||
Income taxes payable | 1,494 | 17 | ||
Provision for bonuses | 72 | 161 | ||
Other | 1,034 | 609 | ||
Total current liabilities | 20,005 | 22,237 | ||
Non-current liabilities | ||||
Long-term borrowings | 671 | 591 | ||
Retirement benefit liability | 378 | 370 | ||
Other | 45 | 45 | ||
Total non-current liabilities | 1,096 | 1,007 | ||
Total liabilities | 21,101 | 23,245 | ||
Net assets | ||||
Shareholders' equity | ||||
Share capital | 2,043 | 2,043 | ||
Capital surplus | 1,814 | 1,814 | ||
Retained earnings | 7,691 | 5,439 | ||
Treasury shares | (195) | (195) | ||
Total shareholders' equity | 11,353 | 9,101 | ||
Accumulated other comprehensive income | ||||
Valuation difference on available-for-sale securities | 193 | 277 | ||
Total accumulated other comprehensive income | 193 | 277 | ||
Total net assets | 11,547 | 9,379 | ||
Total liabilities and net assets | 32,649 | 32,624 |
Quarterly consolidated statement of income | |||
(Millions of yen) | |||
Three months ended October 31, 2024 | Three months ended October 31, 2025 | ||
Net sales | 14,596 | 15,712 | |
Cost of sales | 2,695 | 3,083 | |
Gross profit | 11,901 | 12,628 | |
Selling, general and administrative expenses | |||
Research and development expenses | 337 | 332 | |
Advertising expenses | 7,943 | 11,434 | |
Commission expenses | 991 | 1,325 | |
Amortization of goodwill | 18 | 8 | |
Other | 1,728 | 2,040 | |
Total selling, general and administrative expenses | 11,018 | 15,140 | |
Operating profit (loss) | 882 | (2,511) | |
Non-operating income | |||
Interest income | 1 | 8 | |
Dividend income | 2 | 2 | |
Foreign exchange gains | 2 | 0 | |
Subsidy income | 62 | 23 | |
Gain on investments in investment partnerships | 4 | 5 | |
Share of profit of entities accounted for using equity method | - | 7 | |
Outsourcing service income | 4 | 4 | |
Other | 9 | 11 | |
Total non-operating income | 87 | 63 | |
Non-operating expenses | |||
Interest expenses | 24 | 25 | |
Share of loss of entities accounted for using equity method | 43 | - | |
Commission expenses | 2 | 145 | |
Other | 11 | 25 | |
Total non-operating expenses | 80 | 196 | |
Ordinary profit (loss) | 888 | (2,644) | |
Extraordinary income | |||
Gain on sale of non-current assets | - | 4 | |
Total extraordinary income | - | 4 | |
Profit (loss) before income taxes | 888 | (2,640) | |
Income taxes | 527 | (749) | |
Profit (loss) | 360 | (1,891) | |
Profit (loss) attributable to owners of parent | 360 | (1,891) | |